• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过多重免疫组织化学技术定义胃癌中的巨噬细胞空间异质性。

Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry.

机构信息

Upper Gastrointestinal Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia.

Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, 3010, Australia.

出版信息

Nat Commun. 2019 Sep 2;10(1):3928. doi: 10.1038/s41467-019-11788-4.

DOI:10.1038/s41467-019-11788-4
PMID:31477692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6718690/
Abstract

Tumor-associated macrophages (TAMs), one of the most abundant immune components in gastric cancer (GC), are difficult to characterize due to their heterogeneity. Multiple approaches have been used to elucidate the issue, however, due to the tissue-destructive nature of most of these methods, the spatial distribution of TAMs in situ remains unclear. Here we probe the relationship between tumor context and TAM heterogeneity by multiplex immunohistochemistry of 56 human GC cases. Using distinct expression marker profiles on TAMs, we report seven predominant populations distributed between tumor and non-tumor tissue. TAM population-associated gene signatures reflect their heterogeneity and polarization in situ. Increased density of CD163+ (CD206-) TAMs with concurrent high CD68 expression is associated with upregulated immune-signaling and improved patient survival by univariate, but not multivariate analysis. CD68-only and CD206+ TAMs are correlated with high PDL1 expression.

摘要

肿瘤相关巨噬细胞(TAMs)是胃癌(GC)中最丰富的免疫成分之一,由于其异质性,难以进行特征描述。已经使用了多种方法来阐明这个问题,但是,由于大多数这些方法都具有组织破坏性,TAMs 在原位的空间分布仍然不清楚。在这里,我们通过对 56 个人类 GC 病例进行多重免疫组织化学染色来探究肿瘤背景与 TAM 异质性之间的关系。使用 TAMs 上不同的表达标记物特征,我们报告了在肿瘤组织和非肿瘤组织之间分布的七个主要群体。TAM 群体相关的基因特征反映了它们在原位的异质性和极化。CD163+(CD206-)TAMs 的密度增加伴随着 CD68 表达的增加,与上调的免疫信号相关,并通过单因素但不是多因素分析与患者生存改善相关。仅 CD68 和 CD206+TAMs 与高 PD-L1 表达相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228b/6718690/872a5ca28692/41467_2019_11788_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228b/6718690/f0f104c7686d/41467_2019_11788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228b/6718690/e8d59efa8d6b/41467_2019_11788_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228b/6718690/7c0ee0957180/41467_2019_11788_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228b/6718690/872a5ca28692/41467_2019_11788_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228b/6718690/f0f104c7686d/41467_2019_11788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228b/6718690/e8d59efa8d6b/41467_2019_11788_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228b/6718690/7c0ee0957180/41467_2019_11788_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228b/6718690/872a5ca28692/41467_2019_11788_Fig7_HTML.jpg

相似文献

1
Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry.通过多重免疫组织化学技术定义胃癌中的巨噬细胞空间异质性。
Nat Commun. 2019 Sep 2;10(1):3928. doi: 10.1038/s41467-019-11788-4.
2
Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer.极化的 CD163+ 肿瘤相关巨噬细胞与胃癌中的血管生成增加和 CXCL12 表达相关。
Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):357-365. doi: 10.1016/j.clinre.2015.09.005. Epub 2015 Oct 23.
3
Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma.M2巨噬细胞的预后意义取决于微卫星不稳定型胃癌中肿瘤相关巨噬细胞与肿瘤浸润淋巴细胞的比例平衡。
PLoS One. 2015 Dec 29;10(12):e0144192. doi: 10.1371/journal.pone.0144192. eCollection 2015.
4
CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.CD86⁺/CD206⁺,两极分化的肿瘤相关巨噬细胞,可预测肝细胞癌患者的预后。
Int J Mol Sci. 2016 Mar 1;17(3):320. doi: 10.3390/ijms17030320.
5
The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.肿瘤内分布影响 CD68 和 CD204 阳性巨噬细胞在非小细胞肺癌中的预后影响。
Lung Cancer. 2018 Sep;123:127-135. doi: 10.1016/j.lungcan.2018.07.015. Epub 2018 Jul 19.
6
Plasmablastic Lymphomas: Characterization of Tumor Microenvironment Using CD163 and PD-1 Immunohistochemistry.浆母细胞淋巴瘤:利用CD163和PD-1免疫组织化学对肿瘤微环境进行特征分析
Ann Clin Lab Sci. 2020 Mar;50(2):213-218.
7
CD163CD204 tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma.CD163CD204 肿瘤相关巨噬细胞通过产生白细胞介素-10 和 PD-L1 促进口腔鳞状细胞癌中的 T 细胞调节。
Sci Rep. 2017 May 11;7(1):1755. doi: 10.1038/s41598-017-01661-z.
8
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.CD68、CD163 和基质金属蛋白酶 9(MMP-9)在乳腺肿瘤微环境中的共定位在 ER 阳性和阴性癌症中的生存预测结果不同。
Breast Cancer Res. 2018 Dec 17;20(1):154. doi: 10.1186/s13058-018-1076-x.
9
The role of the immunoescape in colorectal cancer liver metastasis.免疫逃避在结直肠癌肝转移中的作用。
PLoS One. 2021 Nov 19;16(11):e0259940. doi: 10.1371/journal.pone.0259940. eCollection 2021.
10
Differences in PD-L1-Expressing Macrophages and Immune Microenvironment in Testicular Germ Cell Tumors.PD-L1 表达的巨噬细胞和睾丸生殖细胞肿瘤免疫微环境的差异。
Am J Clin Pathol. 2020 Feb 8;153(3):387-395. doi: 10.1093/ajcp/aqz184.

引用本文的文献

1
Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial.安罗替尼联合信迪利单抗作为晚期结直肠癌患者的一线治疗(APICAL-CRC):一项开放标签、单臂、II期试验。
Signal Transduct Target Ther. 2025 Sep 16;10(1):301. doi: 10.1038/s41392-025-02383-9.
2
Enhancing natural killer cell anti-tumour activity through macrophage manipulation.通过巨噬细胞调控增强自然杀伤细胞的抗肿瘤活性。
Front Immunol. 2025 Aug 29;16:1656925. doi: 10.3389/fimmu.2025.1656925. eCollection 2025.
3
Combined single-cell RNA-seq and bulk RNA-seq construction of M2 TAMs signature for predicting HNSCC prognosis and immunotherapy.

本文引用的文献

1
A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment.小鼠大脑小胶质细胞单细胞图谱揭示了由个体发生和组织环境塑造的独特转录特征。
Nat Neurosci. 2019 Jun;22(6):1021-1035. doi: 10.1038/s41593-019-0393-4. Epub 2019 May 6.
2
The Myeloid Cell Compartment-Cell by Cell.髓系细胞室-逐个细胞。
Annu Rev Immunol. 2019 Apr 26;37:269-293. doi: 10.1146/annurev-immunol-042718-041728. Epub 2019 Jan 16.
3
Spatial Mapping of Myeloid Cells and Macrophages by Multiplexed Tissue Staining.
联合单细胞RNA测序和批量RNA测序构建M2肿瘤相关巨噬细胞特征以预测头颈部鳞状细胞癌的预后和免疫治疗
Front Immunol. 2025 Aug 12;16:1620931. doi: 10.3389/fimmu.2025.1620931. eCollection 2025.
4
Heterogeneity and distribution characteristics of tertiary lymphoid structures predict prognostic outcome in esophageal squamous cell carcinoma.三级淋巴结构的异质性和分布特征可预测食管鳞状细胞癌的预后结果。
Front Immunol. 2025 Aug 8;16:1606499. doi: 10.3389/fimmu.2025.1606499. eCollection 2025.
5
The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.免疫特征可预测胃癌/胃食管交界癌对一线抗程序性死亡蛋白1(PD-1)阻断治疗或化疗的反应。
BMC Cancer. 2025 Aug 25;25(1):1369. doi: 10.1186/s12885-025-14805-6.
6
Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments.肿瘤微环境中肿瘤相关巨噬细胞的双重作用及治疗靶点
Signal Transduct Target Ther. 2025 Aug 25;10(1):268. doi: 10.1038/s41392-025-02325-5.
7
Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy.纳米医学驱动的肿瘤葡萄糖代谢重编程以增强癌症免疫治疗
Acta Pharm Sin B. 2025 Jun;15(6):2845-2866. doi: 10.1016/j.apsb.2025.04.002. Epub 2025 Apr 4.
8
ONO-4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.ONO-4578联合纳武利尤单抗治疗不可切除的晚期或复发性胃癌或胃食管交界癌
Cancer Sci. 2025 Sep;116(9):2523-2536. doi: 10.1111/cas.70130. Epub 2025 Jul 6.
9
Gastric Cancer Genetics and Its Implications for Diagnosis, Prognosis, and Treatment of the Disease.胃癌遗传学及其对该疾病诊断、预后和治疗的意义。
Korean J Helicobacter Up Gastrointest Res. 2024 Jun;24(2):103-112. doi: 10.7704/kjhugr.2024.0018. Epub 2024 Jun 10.
10
Quantitative benchmarking of nuclear segmentation algorithms in multiplexed immunofluorescence imaging for translational studies.用于转化研究的多重免疫荧光成像中核分割算法的定量基准测试
Commun Biol. 2025 May 30;8(1):836. doi: 10.1038/s42003-025-08184-8.
通过多重组织染色对髓细胞和巨噬细胞进行空间定位。
Front Immunol. 2018 Dec 14;9:2925. doi: 10.3389/fimmu.2018.02925. eCollection 2018.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Diverse Functions of Macrophages in Different Tumor Microenvironments.肿瘤微环境中巨噬细胞的多样化功能。
Cancer Res. 2018 Oct 1;78(19):5492-5503. doi: 10.1158/0008-5472.CAN-18-1367. Epub 2018 Sep 11.
6
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma.多重免疫组化准确定义转移性黑色素瘤的免疫背景。
Sci Rep. 2018 Jul 24;8(1):11158. doi: 10.1038/s41598-018-28944-3.
7
Quantitative analysis of competitive cytokine signaling predicts tissue thresholds for the propagation of macrophage activation.定量分析竞争细胞因子信号转导可预测巨噬细胞激活传播的组织阈值。
Sci Signal. 2018 Jul 24;11(540):eaaf3998. doi: 10.1126/scisignal.aaf3998.
8
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.PD-1 抑制治疗转移性胃癌的临床反应的全面分子特征分析。
Nat Med. 2018 Sep;24(9):1449-1458. doi: 10.1038/s41591-018-0101-z. Epub 2018 Jul 16.
9
The metabolic axis of macrophage and immune cell polarization.巨噬细胞和免疫细胞极化的代谢轴。
Dis Model Mech. 2018 Jul 6;11(8):dmm034462. doi: 10.1242/dmm.034462.
10
Distribution pattern of tumor associated macrophages predicts the prognosis of gastric cancer.肿瘤相关巨噬细胞的分布模式可预测胃癌的预后。
Oncotarget. 2017 Oct 6;8(54):92757-92769. doi: 10.18632/oncotarget.21575. eCollection 2017 Nov 3.